Thomas DiRaimondo

JANX

Thomas DiRaimondo serves as Chief Scientific Officer at Janux Therapeutics, Inc. (JANX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$266.1K

Net Position

Net Seller

$266.1K

Companies Traded

JANX

Active Period

Sep 2024 – Jan 2026

2 total trades

Most Recent

Sell JANX

Jan 2, 2026 · $34.4K

Thomas DiRaimondo's Insider Trading at Janux Therapeutics, Inc. (JANX)

Buys

0 · $0.00

Sells

2 · $266.1K

Total Shares Bought

Total Shares Sold

7,505

JANX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 2, 2026	Sell	2,505	$13.73	$34.4K	0
Sep 27, 2024	Sell	5,000	$46.34	$231.7K	98,613

Related Insiders

Janeen Noel Doyle

officer: Chief Corp. & Bus. Dev. Ofcr

JANXSell · Jun 4, 2026

Maria Dobek

Vice President, Accounting

JANXSell · May 13, 2026

David Alan Campbell

President and CEO

JANXSell · Jan 2, 2026

Zachariah McIver

Chief Medical Officer

JANXSell · Jan 2, 2026

Andrew Hollman Meyer

Chief Business Officer

JANXSell · Jan 2, 2026

Charles M. Winter

Chief Technical Officer

JANXSell · Jan 2, 2026

Explore More Insider Trading Data

JANX Insider Trading Activity

View all insider trades at Janux Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity